Clinical Trial Update: Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on an NK-1 receptor antagonist for prevention of postoperative nausea and vomiting in female patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• NK-1 anti-emetic medication (unnamed in report)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative | Phase 2 | Status: COMPLETED